|
|
|
|
NARFE July 2024
Have you heard the good news? Earlier this month, the U.S. Food and Drug Administration (FDA) approved donanemab (Kisunla™) for the treatment of Alzheimer's disease. There are now multiple FDA-approved treatments that change the course of Alzheimer's in a meaningful way for people in the early stages of the disease. Thanks to your support, people living with Alzheimer's will have more time to take part in daily life and live independently.
This milestone is an important step forward in the fight to end Alzheimer's — and we would not have reached this day without you. Your support is driving us toward new treatments and diagnostic tools, quality care, prevention and, ultimately, a cure. Thank you, NARFE members, for your ongoing partnership and passion for a world without Alzheimer's and all other dementia.
|
|
|
Association welcomes FDA approval of Alzheimer's treatment donanemab
The Alzheimer's Association celebrates the U.S. Food and Drug Administration's (FDA) action to approve donanemab (Kisunla™) for the treatment of people living with early symptomatic Alzheimer's disease, which includes mild cognitive impairment and the mild dementia stage of Alzheimer's disease, with confirmed amyloid plaques. With multiple FDA-approved Alzheimer's treatments now available, early detection and diagnosis are even more critical to ensure individuals receive the most benefit. Learn more.
|
|
|
|
|
Eating may become a challenge as Alzheimer's progresses
Distractions, too many choices and changes in perception, taste and smell can make eating more difficult for a person living in the middle and late stages of Alzheimer's. As the person's cognitive function declines, they may become overwhelmed or have difficulty with utensils. Learn more.
|
|
|
|
|
In-home services can help people living with Alzheimer's and caregivers
In-home care for a person living with Alzheimer's includes a wide range of services provided in the home rather than in a hospital or residential community. It can allow an individual living with Alzheimer's or another dementia to stay in their home and can be of great assistance to their caregiver. Learn more.
|
|
|
|
|
Heat precautions for families facing Alzheimer's and other dementias
People living with Alzheimer's or another dementia can be vulnerable during extreme weather because their judgment may be impaired, and they may be unable to communicate. It's important to take extra precautions with these individuals when there is extreme heat or other excessive weather conditions. Learn more.
|
|
|
|
|
View Past Issues
|
|
|
|
|
NARFE 2026 Goal: $17 Million
|
|
|
|
24/7 Helpline: 1-800-272-3900
|
|
